הרשמו על מנת ליצור התראות עבור מכשירים,
אירועים כלכליים ותוכן מאת כותבים אחריהם אתם עוקבים
הרשמה חינם כבר יש לך חשבון? כניסה
ציטוטים
כל סוגי המכשירים
- כל סוגי המכשירים
- מדדים
- מניות
- קרנות סל
- קרנות נאמנות
- סחורות
- מט"ח
- קריפטו
- אג"ח
- תעודות
אנא נסו לחפש ביטוי שונה
👁 בואו לזהות מניות מנצחות כמו המקצוענים, עם תובנות באמצעות AI. מבצע סייבר מאנדיי מסתיים בקרוב!
למימוש המבצע
(0P00000RPL) Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD
הוסף ל/הסר מתיק ההשקעות
הוסף לרשימת מעקב
51.540
+0.110
+0.21%
20/12 - סגור. מטבע USD
- דירוג Morningstar:
- סך נכסים: 3.79B
Janus Capital Funds plc - Janus Global Life Scienc
51.540
+0.110
+0.21%
- כללי
- גרף
- ניתוח טכני
- פורום
- סקירה
- פרופיל
- נתונים היסטוריים
- החזקות
0P00000RPL - סקירה
בדף זה תמצאו מבט עומק על פרופיל חברת Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD. קבלו מידע על המנהלים הבכירים, סך הנכסים, אסטרטגיית ההשקעות ופרטי ההתקשרות של 0P00000RPL – וכן מידע נוסף.
פרטי התקשרות
כתובת
201 Bishopsgate
London,London EC2M 3AE
United Kingdom
London,London EC2M 3AE
United Kingdom
טלפון
8002270486
אינטרנט
www.janushenderson.com
מנהלים בכירים
| שם | כותרת | משנת | עד שנת |
|---|---|---|---|
| Daniel Lyons | Portfolio Manager | 2023 | עכשיו |
| ביוגרפיה | "Daniel Lyons is a Portfolio Manager and Research Analyst at Janus Henderson Investors responsible for co-managing the Biotechnology strategy since 2018. Daniel started consulting for Janus in 1997 and joined the Health Care Sector Research Team full time in 2000. As a research analyst, he focuses on the biotechnology and life science tools sectors. Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 19 years of financial industry experience." | ||
| Andy Acker | Portfolio Manager | 2007 | עכשיו |
| ביוגרפיה | "Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience." | ||
| Ethan Lovell | Portfolio Manager | 2015 | 2022 |
| ביוגרפיה | Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. | ||
| Thomas R. Malley | Portfolio Manager | 2000 | 2007 |
| ביוגרפיה | Malley joined Janus Capital Corporation in 1991 and currently serves as a portfolio manager. Malley holds the Chartered Financial Analyst designation. | ||
כתבו דעתכם על Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD
האם אתה בטוח שאתה רוצה למחוק את הגרף?
מחק ביטול
האם להחליף את התרשים המצורף עם תרשים חדש?
החלף ביטול
הנחיות לכתיבת תגובות
הוסף גרף לתגובה
אשרו חסימה
האם אתם בטוחים שברצונכם לחסום את %USER_NAME%?
חסימה תמנע מהמשתמש %USER_NAME% לראות את ההודעות שלכם ב-Investing.com, ולהפך.
המשתמש %USER_NAME% התווסף בהצלחה אל רשימת החסומים
מכיוון שזה עתה בטלתם את חסימת משתמש זה, עליכם להמתין 48 שעות בטרם תוכלו לחדש את החסימה.
דווח/י על תגובה זו
לתחושתי, תגובה זו הנה:
התגובה סומנה
תודה רבה
הדיווח שלך נשלח למנהלי הפורום שלנו לבחינה